Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
FACS analysis of Alpha-synuclein (GFP) on HEK293/Human Alpha-synuclein (GFP) Stable Cell Line.
HEK293/Human Alpha-synuclein (GFP) Stable Cell Line was red line, negative control HEK293 cells was grey line (QC tested).
Immobilized Human Alpha-Synuclein (A53T), His Tag (Cat. No. ALN-H51H5) at 1 μg/mL (100 μL/well) can bind Synuclein alpha/beta Monoclonal Antibody with a linear range of 1-31 ng/mL (QC tested).
The purity of Human Alpha-Synuclein (E46K), Tag Free (Cat. No. ALN-H5117) is more than 95% and the molecular weight of this protein is around 13-20 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Parkinson Disease; Alzheimer Disease; Cognitive Dysfunction; Frontotemporal Dementia | Details |
MEDI-1341 | MEDI-1341; TAK- 341 | Phase 2 Clinical | Astrazeneca Plc, Takeda Pharmaceutical Co Ltd | Parkinson Disease; Multiple System Atrophy | Details |
Lu AF-82422 (Lundbeck A/S) | Lu AF-82422; Lu AF82422; Lu-AF82422 | Phase 2 Clinical | H. Lundbeck A/S, Genmab A/S | Parkinson Disease; Multiple System Atrophy | Details |
Prasinezumab | PRX-002; RG-7935; NEOD-002; RO-7046015 | Phase 2 Clinical | Prothena | Parkinson Disease | Details |
Kenterin | ENT-01; kenterin; Enterin-01 | Phase 2 Clinical | Enterin Inc | Constipation; Parkinson Disease; Dementia | Details |
UB-312 | UB-312 | Phase 2 Clinical | United Neuroscience Ltd | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details |
PBT-434 | PBT-434; ATH-434 | Phase 2 Clinical | Prana Biotechnology Ltd | Multiple System Atrophy | Details |
MT101-5 | MT101-5 | Phase 2 Clinical | Mthera Pharma Co Ltd | Parkinson Disease | Details |
AMDX-2011P | AMDX2011P; AMDX-2011P | Phase 2 Clinical | Amydis Inc | Cerebral Amyloid Angiopathy; Glaucoma, Open-Angle; Parkinson Disease; Amyotrophic Lateral Sclerosis | Details |
ACI-7104 | ACI-7104.056; ACI-7104 | Phase 2 Clinical | Ac Immune Sa | Parkinson Disease | Details |
UCB-0599 | UCB-1332; NPT200-11; UCB-0599 | Phase 2 Clinical | Neuropore Therapies Inc, Novartis Ag | Parkinson Disease | Details |
ION-464 | BIIB-101; IONIS-BIIB6 Rx; ION-464 | Phase 1 Clinical | Ionis Pharmaceuticals Inc | Multiple System Atrophy | Details |
SAR-446159 | ABL-301; SAR-446159 | Phase 1 Clinical | Abl Bio Inc | Parkinson Disease | Details |
ACI-12589 | ACI-12589; a-syn-PET tracer (AC Immune) | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Synucleinopathies | Details |
SNP201 | SNP201; SNP-201 | Phase 1 Clinical | SciNeuro Pharmaceuticals | Parkinson Disease | Details |
[18F]UCB-2897 | Phase 1 Clinical | Invicro Llc | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details | |
ACI-3847 | ACI-3847; 18F-ACI-3847 | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Neurodegenerative Diseases | Details |
UCB-7853 | UCB-7853 | Phase 1 Clinical | Ucb Biopharma Srl | Parkinson Disease | Details |
Emrusolmin | Anle-138b; TEV-56286 | Phase 1 Clinical | Modag Gmbh | Parkinson Disease | Details |
Syneuro (Indus Biotech) | Clinical | Indus Biotech Pvt Ltd | Parkinson Disease | Details | |
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Parkinson Disease; Alzheimer Disease; Cognitive Dysfunction; Frontotemporal Dementia | Details |
MEDI-1341 | MEDI-1341; TAK- 341 | Phase 2 Clinical | Astrazeneca Plc, Takeda Pharmaceutical Co Ltd | Parkinson Disease; Multiple System Atrophy | Details |
Lu AF-82422 (Lundbeck A/S) | Lu AF-82422; Lu AF82422; Lu-AF82422 | Phase 2 Clinical | H. Lundbeck A/S, Genmab A/S | Parkinson Disease; Multiple System Atrophy | Details |
Prasinezumab | PRX-002; RG-7935; NEOD-002; RO-7046015 | Phase 2 Clinical | Prothena | Parkinson Disease | Details |
Kenterin | ENT-01; kenterin; Enterin-01 | Phase 2 Clinical | Enterin Inc | Constipation; Parkinson Disease; Dementia | Details |
UB-312 | UB-312 | Phase 2 Clinical | United Neuroscience Ltd | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details |
PBT-434 | PBT-434; ATH-434 | Phase 2 Clinical | Prana Biotechnology Ltd | Multiple System Atrophy | Details |
MT101-5 | MT101-5 | Phase 2 Clinical | Mthera Pharma Co Ltd | Parkinson Disease | Details |
AMDX-2011P | AMDX2011P; AMDX-2011P | Phase 2 Clinical | Amydis Inc | Cerebral Amyloid Angiopathy; Glaucoma, Open-Angle; Parkinson Disease; Amyotrophic Lateral Sclerosis | Details |
ACI-7104 | ACI-7104.056; ACI-7104 | Phase 2 Clinical | Ac Immune Sa | Parkinson Disease | Details |
UCB-0599 | UCB-1332; NPT200-11; UCB-0599 | Phase 2 Clinical | Neuropore Therapies Inc, Novartis Ag | Parkinson Disease | Details |
ION-464 | BIIB-101; IONIS-BIIB6 Rx; ION-464 | Phase 1 Clinical | Ionis Pharmaceuticals Inc | Multiple System Atrophy | Details |
SAR-446159 | ABL-301; SAR-446159 | Phase 1 Clinical | Abl Bio Inc | Parkinson Disease | Details |
ACI-12589 | ACI-12589; a-syn-PET tracer (AC Immune) | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Synucleinopathies | Details |
SNP201 | SNP201; SNP-201 | Phase 1 Clinical | SciNeuro Pharmaceuticals | Parkinson Disease | Details |
[18F]UCB-2897 | Phase 1 Clinical | Invicro Llc | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details | |
ACI-3847 | ACI-3847; 18F-ACI-3847 | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Neurodegenerative Diseases | Details |
UCB-7853 | UCB-7853 | Phase 1 Clinical | Ucb Biopharma Srl | Parkinson Disease | Details |
Emrusolmin | Anle-138b; TEV-56286 | Phase 1 Clinical | Modag Gmbh | Parkinson Disease | Details |
Syneuro (Indus Biotech) | Clinical | Indus Biotech Pvt Ltd | Parkinson Disease | Details |
This web search service is supported by Google Inc.